Mass spectrometry in the search for uremic toxins

Mass Spectrometry Reviews

Volumn 16, Issue 6, 1997, Pages 307-332

  Niwa, Toshimitsu ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TOXIN;

CHEMICALLY INDUCED DISORDER; HUMAN; MASS FRAGMENTOGRAPHY; REVIEW; UREMIA;

GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; TOXINS, BIOLOGICAL; UREMIA;

EID: 0031265505     PISSN: 02777037     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2787(1997)16:6<307::AID-MAS1>3.0.CO;2-L     Document Type: Article

References (106)

1. Abreo, K.; Sella, M.; Gautreaux, S.; De Smet, R.; Vogeleere, P.; Ringoir, S.; Vanholder, R. "p-Cresol, a uremic compound, enhances the uptake of aluminum in hepatocytes." J. Am. Soc. Nephrol. 1997, 8, 935-942.
2. Asaba, H.; Zimmerman, L.; Bergstrom, J. "On drug artifacts in middle molecule analysis." Nephron 1985, 39, 73-76.
3. Bachmann, J.; Tepel, M.; Raidt, H.; Riezler, R.; Graefe, U.; Langer, K.; Zidek, W. "Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients." J. Am. Soc. Nephrol. 1995, 6, 121-125.
4. Bergström, J. "Urémie toxicity." In Nutritional Management of Renal Disease, Kopple, J. D., Massry, S. G., Eds.; Williams & Wilkins: Baltimore, 1997, 97-190.
5. Bisse, E.; Huaman, G. P.; Horth, P.; Busse, G. A.; Lizama, M.; Kramer, G. A.; Haehnel, W.; Wieland, H. "Heterogeneity of hemoglobin A1d: assessment and partial characterization of two new minor hemoglobins, A1d3a and A1d3b, increased in uremic and diabetic patients, respectively." J. Chromatogr. B 1996, 687, 349-356.
6. Bostom, A. G.; Lathrop, L. "Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes." Kidney Int. 1997, 52, 10-20.
7. Bowmer, C. J.; Lindup, W. E. "Decreased drug binding in uremia: effect of indoxyl sulphate and other endogenous substances on the binding of drugs and dyes to human albumin." Biochem. Pharmacol. 1982, 31, 319-323.
8. Brunner, H.; Weisshaar, G.; Friebolin, H.; Baumann, W.; Mann, H.; Sieberth, H. G.; Opferkuch, H. J. "Isolation of unusually composed sialyl-compounds from hemofiltrate." Int. J. Artif. Organs 1989, 12, 755-761.
9. 2-microglobulin amyloid synovial tissue and articular cartilage." Nephron 1993, 65, 559-563.
10. Dennis, V. W.; Robinson, K. "Homocysteinemia and vascular disease in end-stage renal disease." Kidney Int. 1996, 50 (Suppl. 57), S11-S17.
11. Dowty, B.; Carlisle, D.; Laseter, J. L.; Gonzalez, F. M. "Gas chromatographic mass spectrometric computer analysis of volatile components in blood plasma from hemodialysis patients." Biomed. Mass Spectrom. 1975, 2, 142-147.
12. Dzurik, R.; Spustova, V.; Lajdova, I. "Inhibition of glucose utilization in isolated rat soleus muscle by pseudouridine: implications for renal failure." Nephron 1993a, 65, 108-110.
13. Dzurik, R.; Spustova, V. "Accumulated end products participate in glucose intolerance and insulin resistance in uremia." Nephron 1993b, 65, 481.
14. Everts, M. E.; Lim, C. F.; Moerings, E. P.; Tempelaars, A. M.; van Toor, H.; Docter, R.; de Jong, M.; Krenning, E. P.; Hennemann, G. "Effects of a furan fatty acid and indoxyl sulfate on thyroid hormone uptake in cultured anterior pituitary cells." Am. J. Physiol. 1995, 268, E974-979.
15. Faguer, P.; Man, N. K.; Cueille, G.; Funck-Brentano, J. L. "Drug interaction in middle molecule analysis, with special reference to acetylsalicylic acid." Artif. Organs 1984, 8, 226-229.
16. Farreli, J.; Shoemaker, J. D.; Otti, T.; Jordan, W.; Schoch, L.; Neu, L. T.; Bastani, B. "Primary hyperoxaluria in an adult with renal failure, livedo reticularis, retinopathy, and peripheral neuropathy." Am. J. Kidney Dis. 1997, 29, 947-952.
17. Födinger, M.; Mannhalter, C.; Wölfl, G.; Pabinger, I.; Müller, E.; Schmid, R.; Hörl, W. H.; Sunder, P. G. "Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients." Kidney Int. 1997, 52, 517-523.
18. France, N. C.; Holland, P. T.; Wallace, M. R. "Contribution of dialysis to endogenous oxalate production in patients with chronic renal failure." Clin. Chem. 1994, 40, 1544-1548.
19. 2-microglobulin: a possible new uremic toxin?" Int. J. Artif. Organs 1988, 11, 3-5.
20. Gulyassy, P. F.; Bottini, A. T.; Jarrard, E. A.; Stanfel, L. A. "Isolation of inhibitors of ligand: albumin-binding from uremic body fluids and normal urine." Kidney Int. 1983, 24, s238-s242.
21. Gulyassy, P. F.; Bottini, A. T.; Stanfel, L. A.; Jarrard, E. A.; Depner, T. A. "Isolation and chemical identification of inhibitors of plasma ligand binding." Kidney Int. 1986, 30, 391-398.
22. Guttormsen, A. B.; Ueland, P. M.; Svarstad, E.; Refsum, H. "Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure." Kidney Int. 1997, 52, 495-502.
23. Hörkkö, S.; Savolainen, M. J.; Kervinen, K.; Kesäniemi, Y. A. "Carbamylation-induced alterations in low-density lipoprotein metabolism." Kidney Int. 1992, 41, 1175-1181.
24. Hörkkö, S.; Huttunen, K.; Kervinen, K.; Kesäniemi, Y. A. "Decreased clearance of uraemic and mildly carbamylated low-density lipoprotein." Eur. J. Clin. Invest. 1994, 24, 105-113.
25. Inouye, M.; Mio, T.; Sumino, K. "Measurement of inositol in uremic serum by selected ion monitoring." Jpn. J. Med. 1988, 27, 29-33.
26. 26Al tracer study employing accelerator mass spectrometry." Nephrol. Dial. Transplant. 1997, 12, 1369-1375.
27. Jaconi, S.; Rose, K.; Hughes, G. J.; Saurat, J. H.; Siegenthaler, G. "Characterization of two post-translationally processed forms of human serum retinol-binding protein: altered ratios in chronic renal failure." J. Lipid Res. 1995, 36, 1247-1253.
28. Kaplan, B.; Gotfried, M.; Cojocaru, M.; Pras, M.; Ravid, M. "Bound amino acids in uremic sera: Search for peptidic middle molecules by preparative polyamide gel electrophoresis and high performance liquid chromatography." Clin. Chim. Acta 1989, 185, 119-130.
29. 13C]urea and gas chromatography-isotope ratio mass spectrometry (GC-IRMS) analysis." Clin. Sci. 1997, 93, 73-80.
30. Kraus, L. M.; Kraus, A. P. "Tyrosine and N-carbamoyl-tyrosine in end-stage renal disease during continuous ambulatory peritoneal dialysis." J. Lab. Clin. Med. 1991, 118, 555-562.
31. Kraus, L. M.; Elberger, A. J.; Handorf, C. R.; Pabst, M. J.; Kraus, A. P. "Urea-derived cyanate forms ∈-amino-carbamoyl-lysine (homocitrulline) in leukocyte protein in patients with end-stage renal disease on peritoneal dialysis." J. Lab. Clin. Med. 1994, 123, 882-891.
32. Lichtenwalner, D. M.; Sun, B. "Isolation and chemical characterization of 2-hydroxybenzoylglycine as a drug binding inhibitor in uremia." J. Clin. Invest. 1983, 71, 1289-1296.
33. Liebich, H. M.; Wöll, J. "Volatile substances in blood serum: profile analysis and quantitative determination." J. Chromatogr. 1977, 142, 505-516.
34. Liebich, H. M.; Pickert, A.; Tetschner, B. "Gas chromatographic and gas chromatographic-mass spectrometric analysis of organic acids in plasma of patients with chronic renal failure." J. Chromatogr. 1984, 289, 259-266.
35. Lim, C. F.; Bernard, B. F.; de Jong, M.; Docter, R.; Krenning, E. P.; Hennemann, G. "A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia." J. Clin. Endocrinol. Metab. 1993a, 76, 318-324.
36. Lim, C. F.; Stockigt, J. R.; Curtis, A. J.; Wynne, K. N.; Barlow, J. W.; Topliss, D. J. "A naturally occurring furan fatty acid enhances drug inhibition of thyroxine binding in serum." Metabolism 1993b, 42, 1468-1474.
37. Lindner, A.; Vanholder, R.; De, S. R.; Hinds, T. R.; Vogeleere, P.; Sandra, P.; Foxall, P.; Ringoir, S. "HPLC fractions of human uremic plasma inhibit the RBC membrane calcium pump." Kidney Int. 1997, 51, 1042-1052.
38. Lindup, W. E.; Henderson, S. J.; Barker, C. E. "Drug binding in renal disease." In Plasma Bindings of Drugs and its Consequences, Belpaire, F.; Bogaert, M.; Tillement, J. P.; Verbeeck, R., Eds.; Academia Press: Ghent, 1991, 103-120.
39. Mabuchi, H.; Nakahashi, H. "Profiling of endogenous ligand solutes that bind to serum proteins in sera of patients with uremia." Nephron 1986a, 43, 110-116.
40. Mabuchi, H.; Nakahashi, H. "Isolation and characterization of an endogenous drug-binding inhibitor present in uremic serum." Nephron 1986b, 44, 277-281.
41. Mabuchi, H.; Nakahashi, H. "Inhibition of hepatic gluta-thione S-transferase by a major endogenous ligand substances present in uremic serum." Nephron 1988, 49, 281-283.
42. Makita, Z.; Bucala, R.; Rayfield, E. J.; Friedman, E. A.; Kaufman, A. M.; Korbet, S. M.; Barth, R. H.; Winston, J. A.; Fuh, H.; Manogue, K. R.; Cerami, A.; Vlassara, H. "Reactive glycosylation endproducts in diabetic uremia and treatment of renal failure." Lancet 1994, 343, 1519-1522.
43. McNamara, P. J.; Lalka, D.; Gibaldi, M. "Endogenous accumulation products and serum protein binding in uremia." J. Lab. Clin. Med. 1981, 98, 730-740.
44. Miyazaki, T.; Ise, M.; Seo, H.; Niwa, T. "Indoxyl sulfate increases the gene expressions of TGF-β1, TIMP-1 and pro α1(I) collagen in kidneys of uremic rats." Kidney Int. 1997a, 52 (Suppl 62), S15-S22.
45. Miyazaki, T.; Ise, M.; Hirata, M.; Endo, K.; Ito, Y.; Seo, H.; Niwa, T. "Indoxyl sulfate stimulates renal synthesis of transforming growth factor-β1 and progression of renal failure." Kidney Int. 1997b, 52 (Suppl 63), S211-S214.
46. Monti, J. P.; Gallice, P.; Crevat, A.; Murisasco, A. "Identification by nuclear magnetic resonance and mass spectrometry of a glucuronic conjugate of o-hydroxybenzoic acid in normal urine and uremic plasma." Clin. Chem. 1985, 31, 1640-1643.
47. Nakamura, K.; Ienaga, K.; Nakano, K.; Nakai, M.; Nakamura, Y.; Hasegawa, G.; Sawada, M.; Kondo, M.; Mori, H.; Kanatsuna, T. "Creatol, a creatinine metabolite, as a useful determinant of renal function." Nephron 1994, 66, 140-146.
48. Niwa, T.; Ohki, T.; Maeda, K.; Saito, A.; Ohta, K.; Kobayashi, K. "A gas chromatographic-mass spectrometric assay for nine hydroxyphenolic acids in uremic serum." Clin. Chim. Acta 1979a, 96, 247-254.
49. Niwa, T.; Ohki, T.; Maeda, K.; Saito, A.; Kobayashi, K. "Pattern of aliphatic dicarboxylic acids in uremic serum including a new organic acid, 2,4-dimethyladipic acid." Clin. Chim. Acta 1979b, 99, 71-83.
50. Niwa, T.; Maeda, K.; Ohki, T.; Saito, A.; Kobayashi, S.; Asada, H.; Kobayashi, K. "Profiling of uremic ultrafiltrate using high resolution gas chromatography-mass spectrometry - identification of 6 polyphenols." Clin. Chim. Acta 1980, 108, 113-119.
51. Niwa, T.; Maeda, K.; Ohki, T.; Saito, A.; Kobayashi, K. "A gas chromatographic-mass spectrometric analysis for phenols in uremic serum." Clin. Chim. Acta 1981, 110, 51-57.
52. Niwa, T.; Yamamoto, N.; Maeda, K.; Yamada, K.; Ohki, T.; Mori, M. "Gas chromatographic-mass spectrometric analysis of polyols in urine and serum of uremic patients." J. Chromatogr. 1983, 277, 25-39.
53. Niwa, T.; Yamada, K.; Ohki, T.; Saito, A.; Mori, M. "Identification of 6-deoxyallitol and 6-deoxygulitol in human urine. Electron-impact mass spectra of eight isomers of 6-deoxyhexitol." J. Chromatogr. 1984, 336, 345-350.
54. Niwa, T. "Metabolic profiling with gas chromatography-mass spectrometry and its application to clinical medicine." J. Chromatogr. 1986a, 379, 313-345.
55. Niwa, T.; Asada, H.; Maeda, K.; Yamada, K.; Ohki, T.; Saito, A. "Profiling of organic acids and polyols in nerves of uremic and non-uremic patients." J. Chromatogr. 1986b, 377, 15-22.
56. Niwa, T.; Takeda, N.; Tatematsu, A.; Maeda, K. "Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography." Clin. Chem. 1988a, 34, 2264-2267.
57. Niwa, T.; Takeda, N.; Maeda, K.; Shibata, M.; Tatematsu, A. "Accumulation of furancarboxylic acids in uremic serum as inhibitors of drug-binding." Clin. Chim. Acta 1988b, 173, 127-138.
58. Niwa, T.; Sobue, G.; Maeda, K.; Mitsuma, T. "Myoinositol inhibits proliferation of cultured Schwann cells: evidence for neurotoxicity of myoinositol." Nephrol. Dial. Transplant. 1989, 4, 662-666.
59. Niwa, T.; Yazawa, T.; Kodama, T.; Uehara, Y.; Maeda, K.; Yamada, K. "Efficient removal of albumin-bound furancarboxylic acid; an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis." Nephron 1990, 56, 241-245.
60. Niwa, T.; Yoshizumi, H.; Emoto, Y.; Miyazaki, T.; Hashimoto, N.; Takeda, N.; Tatematsu, A.; Maeda, K. "Accumulation of quinolinic acid in uremic serum and its removal by hemodialysis." Clin. Chem. 1991a, 37, 159-161.
61. Niwa, T.; Yazawa, T.; Maeda, K. "Methods for removal of protein-bound metabolites accumulated in uremic serum." Artif. Organs 1991b, 14 (suppl 4), 228-229.
62. Niwa, T.; Emoto, Y.; Maeda, K.; Uehara, Y.; Yamada, N.; Shibata, M. "Oral sorbent suppresses accumulation of albumin-bound indoxyl sulphate in serum of haemodialysis patients." Nephrol. Dial. Transplant. 1991c, 6, 105-109.
63. Niwa, T.; Yazawa, T.; Ise, M.; Sugano, M.; Kodama, T.; Uehara, Y.; Maeda, K. "Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats." Nephron 1991d, 57, 84-88.
64. Niwa, T.; Aiuchi, T.; Nakaya, K.; Emoto, Y.; Miyazaki, T.; Maeda, K. "Inhibition of mitochondrial respiration by furancarboxylic acid accumulated in uremic serum in its albumin-bound and non-dialyzable form." Clin. Nephrol. 1993a, 39, 92-96.
65. Niwa, T. "Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection." Clin. Chem. 1993b, 39, 108-111.
66. Niwa, T.; Ise, M.; Miyazaki, T.; Maeda, K. "Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uremic rats." Nephron 1993c, 65, 82-87.
67. Niwa, T.; Takeda, N.; Yoshizumi, H.; Tatematsu, A.; Ohara, M.; Tomiyama, S.; Niimura, K. "Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum." Biochem. Biophys. Res. Commun. 1993d, 196, 837-843.
68. Niwa, T.; Tohyama, K.; Kato, Y. "Analysis of polyols in uremic serum by liquid chromatography combined with atmospheric pressure chemical ionization mass spectrometry." J. Chromatogr. 1993e, 613, 9-14.
69. Niwa, T.; Ise, M. "Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis." J. Lab. Clin. Med. 1994a, 124, 96-104.
70. Niwa, T.; Ise, M.; Miyazaki, T. "Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate." Am. J. Nephrol. 1994b, 14, 207-212.
71. Niwa, T.; Kawagishi, I.; Ohya, N. "Rapid assay for furancarboxylic acid accumulated in uremic serum using high-performance liquid chromatography and on-line mass spectrometry." Clin. Chim. Acta 1994c, 226, 89-94.
72. Niwa, T.; Dewald, L.; Sone, J.; Miyazaki, T.; Kajita, M. "Quantification of serum 1,5-anhydroglucitol in uremic and diabetic patients by liquid chromatography/mass spectrometry." Clin. Chem. 1994d, 40, 260-264.
73. Niwa, T. "Mass spectrometry in uremia." Clin. Chim. Acta 1995a, 242, 155-187.
74. Niwa, T.; Takeda, N.; Miyazaki, T.; Yoshizumi, H.; Tatematsu, A.; Maeda, A.; Ohara, M.; Tomiyama, S.; Niimura, K. "Elevated serum levels of 3-deoxyglucosone, a potent protein-cross-linking intermediate of the Maillard reaction, in uremic serum," Nephron 1995b, 69, 438-443.
75. Niwa, T.; Asada, H.; Tsutsui, S.; Miyazaki, T. "Efficient removal of albumin-bound furancarboxylic acid by protein-leaking hemodialysis." Am. J. Nephrol. 1995c, 15, 181-185.
76. 2-m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum." Kidney Int. 1996a, 49, 861-867.
77. Niwa, T.; Miyazaki, T.; Tsukushi, S.; Maeda, K.; Tsubakihara, Y.; Owada, A.; Shiigai, T. "Accumulation of indoxyl-β-D-glucuronide in uremic serum: suppression of its production by oral sorbent and efficient removal by hemodialysis." Nephron 1996b, 74, 72-78.
78. ∈-(carboxymethyl)lysine in dialysis-related amyloidosis." Kidney Int. 1996c, 50, 1303-1309.
79. 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis." Kidney Int. 1997a, 51, 187-194.
80. Niwa, T.; Katsuzaki, T.; Ishizaki, Y.; Hayase, F.; Miyazaki, T.; Uematsu, T.; Tatemichi, N.; Takei, Y. "Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes." FEBS Lett. 1997b, 407, 297-302.
81. Niwa, T.; Katsuzaki, T.; Miyazaki, S.; Miyazaki, T.; Ishizaki, Y.; Hayase, F.; Tatemichi, N.; Takei, Y. "Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients." J. Clin. Invest. 1997c, 99, 1272-1280.
82. Niwa, T.; Nomura, T.; Sugiyama, S.; Miyazaki, T.; Tsukushi, S.; Tsutsui, S. "The protein metabolite hypothesis, a model for the progression of renal failure: An oral sorbent lowers indoxyl sulfate levels in undialyzed uremic patients." Kidney Int. 1997d, 52 (Suppl. 62), S23-S28.
83. Nyberg, G.; Sanderson, K.; Andren, P.; Thornwall, M.; Einarsson, M.; Danielson, B.; Nyberg, F. "Isolation of haemorphin-related peptides from filter membranes collected in connection with hemofiltration of human subjects." J. Chromatogr. A 1996, 723, 43-49.
84. Pinkston, D.; Spiteller, G.; von Henning, H.; Matthaei, D. "High-resolution gas chromatography-mass spectrometry of the methyl esters of organic acids from uremic hemofiltrates." J. Chromatogr. 1981, 223, 1-19.
85. Reusche, E.; Seydel, U. "Dialysis-associated encephalopathy: light and electron microscopic morphology and topography with evidence of aluminum by laser microprobe mass analysis." Acta Neuropathol. 1993, 86, 249-258.
86. Roboz, J.; Kappatos, D. C.; Greaves, J.; Holland, J. F. "Determination of polyols in serum by selected ion monitoring." Clin. Chem. 1984, 30, 1611-1615.
87. Rutten, G. A.; Schoots, A. C.; Vanholder, R.; DeSmet, R.; Ringoir, S. M.; Cramers, C. A. "Hexachlorobenzene and 1,1-di(4-chlorophenyl)-2,2-dichloroethene in serum of uremic patients and healthy persons: determination by capillary gas chromatography and electron capture detection." Nephron 1988, 48, 217-221.
88. Schoots, A. C.; Mikkers, F. E. P.; Cramers, C. A. M. G.; Ringoir, S. "Profiling of uremic serum by high-resolution gas chromatography-electron-impact, chemical ionization mass spectrometry." J. Chromatogr. 1979, 164, 1-8.
89. Schoots, A. C.; Mikkers, P.; Cramers, C.; de Smet, R.; Ringoir, S. "Uremic toxins and the elusive middle molecules." Nephron 1984, 38, 1-8.
90. Schoots, A. C.; Homan, H. R.; Gladdines, M. M.; Cramers, C. A. M. G.; de Smet, R.; Ringoir, S. M. G. "Screening of UV-absorbing solutes in uremic serum by reversed phase HPLC - Changes of blood levels in different therapies." Clin. Chim. Acta 1985, 146, 37-51.
91. Schoots, A. C.; Gerlag, P. G. G.; Mulder, A. W.; Peeters, J. A. G.; Cramers, C. A. M. G. "Liquid-chromatographic profiling of solutes in serum of uremic patients undergoing hemodialysis and chronic ambulatory peritoneal dialysis (CAPD); high concentrations of pseudouridine in CAPD patients." Clin. Chem. 1988, 34, 91-97.
92. Smith, J. B.; Shun, S. G.; Sun, Y.; Miesbauer, L. R.; Yang, Z.; Yang, Z.; Zhou, X.; Schwedler, J.; Smith, D. L. "Glutathione adducts, not carbamylated lysines, are the major modification of lens alpha-crystallins from renal failure patients." J. Prot. Chem. 1995, 14, 179-188.
93. Spiteller, M.; Spiteller, G. "Trennung und Charakterisierung saurer Harnbestandteile." J. Chromatogr. 1979, 164, 253-317.
94. Takeda, N.; Niwa, T.; Tatematsu, A.; Suzuki, M. "Identification and quantification of a protein-bound ligand in uremic serum." Clin. Chem. 1987, 33, 682-685.
95. Takeda, N.; Niwa, T.; Maeda, K.; Shibata, M.; Tatematsu, A. "Rapid assay for indoxyl sulphate in uremic serum by internal-surface reversed-phase high-performance liquid chromatography." J. Chromatogr. 1988, 431, 418-423.
96. Takeda, N.; Nakamura, M.; Yoshizumi, H.; Tatematsu, A. "Structural characterization of modified nucleosides in tRNA hydrolysates by frit-fast atom bombardment liquid chromatography/mass spectrometry." Biol. Mass Spectrom. 1994a, 23, 465-474.
97. Takeda, N.; Nakamura, M.; Yoshizumi, H.; Tatematsu, A. "Detection of ribose-methylated nucleotides in Pyrodictium occultum tRNA by liquid chromatography-frit-fast atom bombardment mass spectrometry." J. Chromatogr. 1994b, 660, 223-233.
98. 2-microglobulin glycosylated end products in human serum by matrix-assisted laser desorption/ionization mass spectrometry." Anal. Chem. 1996, 68, 3740-3745.
99. Vanholder, R. C.; Ringoir, S. M. G. "The uremic syndrome." In Oxford Textbook of Clinical Nephrology, Cameron, S.; Davison, A. M.; Grünfeld, J.-P.; Kerr, D.; Ritz, E. Eds.; Oxford University Press: 1992, 1236-1250.
100. Vanholder, R.; De Smet, R.; Waterloos, M. A.; Van Landschoot, N.; Vogeleere, P.; Hoste, E.; Ringoir, S. "Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol." Kidney Int. 1995, 47, 510-517.
101. Williams, R. H.; Shaykh, M.; Ahmed, S.; Musiala, T.; Bazilinski, N.; Dunea, G.; Dubin, A. "Purification and biochemical characterization of xanthopterin from patients with chronic renal failure. II. Biochemical elucidation and structural analysis." Clin. Biochem. 1991, 24, 407-415.
102. Wolthers, B. G.; Meijer, S.; Tepper, T.; Hayer, M.; Elzinga, H. "The determination of oxalate in haemodialysate and plasma: a means to detect and study 'hyperoxaluria' in haemodialyzed patients." Clin. Sci. 1986, 71, 41-47.
103. Zimmerman, L.; Furst, P.; Bergstrom, J.; Jornvall, H. "A new glycine containing compound with a blocked amino group from uremic body fluids." Clin. Nephrol. 1980, 14, 107-111.
104. Zimmerman, L.; Jornvall, H.; Bergstrom, J.; Furst, P.; Sjovall, J. "Characterization of middle molecule compounds." Artif. Organs 1981a, 4 (Suppl), 33-36.
105. Zimmerman, L.; Jornvall, H.; Bergstrom, J.; Furst, P.; Sjovall, J. "Characterization of a double conjugate in uremic body fluids." FEBS Lett. 1981b, 129, 237-240.
106. Zimmerman, L.; Bergstrom, J.; Jornvall, H. "A method for separation of middle molecules by high performance liquid chromatography: Application in studies of glucuronyl-o-hydroxyhippurate in normal and uremic subjects." Clin. Nephrol. 1986, 25, 94-100.